Published in N Engl J Med on May 15, 2008
Recombinant Factor VIIa in Acute Intracerebral Haemorrhage (FAST) | NCT00127283
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) (ERICH) | NCT01202864
Intracerebral haemorrhage. Lancet (2009) 5.15
Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke (2011) 3.04
Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records. Ann Intern Med (2011) 2.87
Prospective validation of the ICH Score for 12-month functional outcome. Neurology (2009) 2.84
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke (2011) 2.81
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med (2011) 2.68
Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology (2011) 2.67
Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol (2012) 2.62
Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke (2011) 2.37
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care (2011) 2.23
Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatr Crit Care Med (2012) 2.13
Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis. Am J Emerg Med (2014) 2.09
Recombinant factor VII is associated with worse survival in complex cardiac surgical patients. Ann Thorac Surg (2014) 2.09
Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke (2012) 1.89
The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke (2009) 1.89
Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol (2010) 1.74
Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab (2012) 1.62
The surgical management of chronic subdural hematoma. Neurosurg Rev (2011) 1.54
Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke (2009) 1.46
Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. Blood Transfus (2015) 1.46
Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol (2014) 1.37
The role of tissue factor and factor VIIa in hemostasis. Anesth Analg (2009) 1.31
Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis (2013) 1.30
Clinical applications of the computed tomography angiography spot sign in acute intracerebral hemorrhage: a review. Stroke (2012) 1.29
Advances in the management of intracerebral hemorrhage. Nat Rev Neurol (2010) 1.28
Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document". Blood Transfus (2013) 1.23
Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices. Stroke (2011) 1.21
Clinical nihilism in neuroemergencies. Emerg Med Clin North Am (2009) 1.20
Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke (2011) 1.19
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol (2013) 1.17
Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study. J Pediatr (2010) 1.15
CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage. Neurocrit Care (2012) 1.14
Bench-to-bedside review: avoiding pitfalls in critical care meta-analysis--funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacy. Crit Care (2008) 1.10
New drugs and devices from 2011 - 2012 that might change your practice. West J Emerg Med (2013) 1.09
Should direct thrombin inhibitors replace warfarin for prophylaxis of thromboembolism in canadians with atrial fibrillation? Can J Hosp Pharm (2012) 1.07
Neuroinflammation after intracerebral hemorrhage. Front Cell Neurosci (2014) 1.05
High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care (2013) 1.04
Pediatric stroke: a review. Emerg Med Int (2011) 1.03
CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke (2009) 1.02
Experimental intracerebral hemorrhage: avoiding pitfalls in translational research. J Cereb Blood Flow Metab (2011) 1.02
Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage. J Neuroinflammation (2013) 1.01
Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage. Fluids Barriers CNS (2014) 1.00
Comparison of hematoma shape and volume estimates in warfarin versus non-warfarin-related intracerebral hemorrhage. Neurocrit Care (2010) 0.98
Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis. CMAJ (2010) 0.98
Modeling intracerebral hemorrhage growth and response to anticoagulation. PLoS One (2012) 0.98
Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis. J Neurosurg (2011) 0.97
Haemostatic drugs for traumatic brain injury. Cochrane Database Syst Rev (2010) 0.96
Clinical review: Critical care management of spontaneous intracerebral hemorrhage. Crit Care (2008) 0.96
PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial. BMC Neurol (2010) 0.95
Clinical review: Traumatic brain injury in patients receiving antiplatelet medication. Crit Care (2012) 0.94
Recruitment and retention of patients into emergency medicine clinical trials. Acad Emerg Med (2010) 0.94
Predictors of late neurological deterioration after spontaneous intracerebral hemorrhage. Neurocrit Care (2013) 0.93
Dynamic nature of the CT angiographic "spot sign". Br J Radiol (2010) 0.93
Hematoma volume measurement in gradient echo MRI using quantitative susceptibility mapping. Stroke (2013) 0.92
The pattern and pace of hyperacute hemorrhage expansion. Neurocrit Care (2012) 0.92
Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization. Contemp Clin Trials (2010) 0.92
Prehospital stroke care: new prospects for treatment and clinical research. Neurology (2013) 0.92
Interpretation and Implementation of Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT II). J Vasc Interv Neurol (2014) 0.92
Brain perihematoma genomic profile following spontaneous human intracerebral hemorrhage. PLoS One (2011) 0.91
Promoting blood circulation for removing blood stasis therapy for acute intracerebral hemorrhage: a systematic review and meta-analysis. Acta Pharmacol Sin (2015) 0.90
Intracerebral hemorrhage--improving outcome by reducing volume? N Engl J Med (2008) 0.90
Factors associated with early deterioration after spontaneous intracerebral hemorrhage: a systematic review and meta-analysis. PLoS One (2014) 0.90
Advances in the management of intracerebral hemorrhage. J Neural Transm (Vienna) (2013) 0.90
Spot sign on 90-second delayed computed tomography angiography improves sensitivity for hematoma expansion and mortality: prospective study. Stroke (2014) 0.89
Intracerebral hemorrhage: a multimodality approach to improving outcome. Transl Stroke Res (2014) 0.89
Treatment targets in intracerebral hemorrhage. Neurotherapeutics (2011) 0.89
Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study. J Neurol (2013) 0.89
SCORE-IT: the Spot Sign score in restricting ICH growth─an Atach-II ancillary study. J Vasc Interv Neurol (2012) 0.88
Intracranial hemorrhage in adult patients with hematological malignancies. BMC Med (2012) 0.88
Prostaglandin E2 EP2 receptor deletion attenuates intracerebral hemorrhage-induced brain injury and improves functional recovery. ASN Neuro (2015) 0.87
European research priorities for intracerebral haemorrhage. Cerebrovasc Dis (2011) 0.87
Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications. Crit Care (2013) 0.87
A prototype device for non-invasive continuous monitoring of intracerebral hemorrhage. J Neurosci Methods (2012) 0.87
Intracranial hemorrhage. Am J Respir Crit Care Med (2011) 0.86
Gender and age interact to affect early outcome after intracerebral hemorrhage. PLoS One (2013) 0.86
The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework. Transfus Med (2012) 0.86
Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage. JAMA Neurol (2013) 0.86
Therapeutic strategies in acute intracerebral hemorrhage. Neurotherapeutics (2012) 0.85
Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage. J Neuroimmune Pharmacol (2015) 0.84
Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies. Lancet Neurol (2013) 0.83
The accuracy of spot sign in predicting hematoma expansion after intracerebral hemorrhage: a systematic review and meta-analysis. PLoS One (2014) 0.83
Rate of Contrast Extravasation on Computed Tomographic Angiography Predicts Hematoma Expansion and Mortality in Primary Intracerebral Hemorrhage. Stroke (2015) 0.83
Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial. J Neurol Neurosurg Psychiatry (2015) 0.83
New trends in resuscitation. Curr Probl Surg (2011) 0.83
Full medical support for intracerebral hemorrhage. Neurology (2015) 0.83
Frequency of hematoma expansion after spontaneous intracerebral hemorrhage in children. JAMA Neurol (2014) 0.82
Anemia is an independent prognostic factor in intracerebral hemorrhage: an observational cohort study. Crit Care (2013) 0.82
The challenge of designing a treatment trial for warfarin-associated intracerebral hemorrhage. Stroke (2009) 0.82
Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2014) 0.82
Time course and predictors of neurological deterioration after intracerebral hemorrhage. Stroke (2015) 0.82
Stroke: is spot sign the answer for intracerebral haemorrhage? Nat Rev Neurol (2012) 0.81
Prediction and observation of post-admission hematoma expansion in patients with intracerebral hemorrhage. Front Neurol (2014) 0.80
Interventional Algorithms for the Control of Coagulopathic Bleeding in Surgical, Trauma, and Postpartum Settings: Recommendations From the Share Network Group. Clin Appl Thromb Hemost (2014) 0.80
Management of intraventricular hemorrhage. Curr Neurol Neurosci Rep (2010) 0.80
Intracerebral hemorrhage: toward physiological imaging of hemorrhage risk in acute and chronic bleeding. Front Neurol (2012) 0.80
The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII. Blood Transfus (2014) 0.80
Rational Use of Recombinant Factor VIIa in Clinical Practice. Indian J Hematol Blood Transfus (2013) 0.80
Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 9.58
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke (2003) 7.75
Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91
Stroke in a biracial population: the excess burden of stroke among blacks. Stroke (2004) 4.83
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med (2012) 3.81
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol (2003) 3.58
Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis (2009) 3.01
The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study. Stroke (2006) 2.56
Plague dynamics are driven by climate variation. Proc Natl Acad Sci U S A (2006) 2.51
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens (2006) 2.37
Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke (2002) 2.36
The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18
Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage. World Neurosurg (2011) 2.11
Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis (2006) 1.91
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke (2008) 1.79
Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke (2004) 1.78
Perihematomal mitochondrial dysfunction after intracerebral hemorrhage. Stroke (2006) 1.76
Plague and the human flea, Tanzania. Emerg Infect Dis (2007) 1.71
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Screening for brain aneurysm in the Familial Intracranial Aneurysm study: frequency and predictors of lesion detection. J Neurosurg (2008) 1.68
Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid. Crit Care Med (2012) 1.67
Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc (2007) 1.66
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke (2005) 1.65
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation (2003) 1.63
Baroreflex: a new therapeutic target in human stroke? Stroke (2009) 1.62
Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage. J Neurosurg (2005) 1.61
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke (2004) 1.60
Surgery for catastrophic epilepsy in infants 6 months of age and younger. J Neurosurg Pediatr (2010) 1.55
NIHSS training and certification using a new digital video disk is reliable. Stroke (2005) 1.53
Clinical prediction of functional outcome after ischemic stroke: the surprising importance of periventricular white matter disease and race. Stroke (2008) 1.52
Diagnostic yield of computed tomography angiography and magnetic resonance angiography in patients with catheter angiography-negative subarachnoid hemorrhage. J Neurosurg (2012) 1.52
Climatically driven synchrony of gerbil populations allows large-scale plague outbreaks. Proc Biol Sci (2007) 1.51
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke (2014) 1.49
Comparison of the European and Japanese guidelines for the management of ischemic stroke. Cerebrovasc Dis (2013) 1.47
A prospective randomized study to evaluate the antipyretic effect of the combination of acetaminophen and ibuprofen in neurological ICU patients. Neurocrit Care (2011) 1.47
Autonomic shift and increased susceptibility to infections after acute intracerebral hemorrhage. Stroke (2011) 1.46
Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage. J Neurosurg (2011) 1.44
Ischaemic stroke: the ocular motor system as a sensitive marker for motor and cognitive recovery. J Neurol Neurosurg Psychiatry (2012) 1.43
Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care (2007) 1.42
Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation (2013) 1.41
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
Comparison of ABC/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhage. Stroke (2005) 1.41
Withholding care in intracerebral hemorrhage: realistic compassion or self-fulfilling prophecy? Neurology (2007) 1.41
Progression of traumatic intracerebral hemorrhage: a prospective observational study. J Neurotrauma (2008) 1.40
Evidence-based medicine: what do you do when there's no evidence? Crit Care Med (2003) 1.39
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran. Thromb Haemost (2015) 1.36
Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab (2006) 1.34
Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage. Neurology (2006) 1.33
Hypernatremia in the neurologic intensive care unit: how high is too high? J Crit Care (2006) 1.31
Late childhood stuttering. J Speech Lang Hear Res (2008) 1.30
Hypothermia for refractory status epilepticus. Neurocrit Care (2008) 1.30
Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol (2003) 1.27
Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke (2007) 1.26
The morbidity related to atrial fibrillation at a tertiary centre in one year: 9.0% of all strokes are potentially preventable. J Clin Neurosci (2002) 1.26
Association of Phosphodiesterase 4D with ischemic stroke: a population-based case-control study. Stroke (2005) 1.25
The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care (2008) 1.25
Sensitivity to changes in disability after stroke: a comparison of four scales useful in clinical trials. J Rehabil Res Dev (2004) 1.24
Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke (2007) 1.24
Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab (2006) 1.22
Diabetes education and care management significantly improve patient outcomes in the dialysis unit. Am J Kidney Dis (2002) 1.21
Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke (2004) 1.20
Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke (2005) 1.18
West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation (2004) 1.18
Postprocedure ischemic events after treatment of intracranial aneurysms with Guglielmi detachable coils. J Neurosurg (2002) 1.18
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke (2009) 1.16